ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,964Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 5176

$2.19M Total Retail Price of All Prescriptions

Rank: 41 out of 5176

467 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 467 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 467 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 21,125 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$95 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 936 880 1 16
ZOLPIDEM TARTRATE 515 448 2 17
SIMVASTATIN 501 469 3 1
CRESTOR 427 393 4 15
AMLODIPINE BESYLATE 406 370 5 2
SYNTHROID 396 336 6 33
LOVAZA 377 353 7 43
LOSARTAN-HYDROCHLOROTHIAZIDE 352 319 8 35
METOPROLOL SUCCINATE 347 331 9 11
METOPROLOL TARTRATE 343 324 10 6
CARVEDILOL 336 305 11 24
PLAVIX 326 290 12 29
INDAPAMIDE 323 300 13 257
ATORVASTATIN CALCIUM 269 260 14 9
MECLIZINE HCL 265 251 15 81
FUROSEMIDE 264 249 16 8
ATENOLOL-CHLORTHALIDONE 248 217 17 161
ACTOPLUS MET 239 230 10 18 268
JANUVIA 234 231 19 25
OMEPRAZOLE 223 192 20 3
LIDODERM 220 205 21 59
LOSARTAN POTASSIUM 216 206 22 14
TAMSULOSIN HCL 204 192 23 20
BENICAR HCT 197 169 24 110
ISOSORBIDE MONONITRATE ER 196 189 25 44
LEVOTHYROXINE SODIUM 192 154 26 4
VOLTAREN 190 183 27 97
DONEPEZIL HCL 183 183 28 28
JANUMET 181 167 29 77
MICARDIS HCT 173 171 30 180
LIPITOR 164 147 31 51
CREON 164 163 31 111
NAMENDA 164 159 31 47
EXFORGE 164 144 31 126
CELEBREX 162 146 35 80
PRAVASTATIN SODIUM 160 145 36 23
DIGOXIN 159 151 37 56
METFORMIN HCL 154 147 38 7
CLOPIDOGREL 154 140 38 26
DIOVAN HCT 150 150 40 39
DIOVAN 149 147 41 19
TRIBENZOR 148 141 42 276
GLIMEPIRIDE 141 136 43 37
ATELVIA 136 136 44 146
HYDROCODONE-ACETAMINOPHEN 136 103 S3 44 27
TRAMADOL HCL-ACETAMINOPHEN 136 132 44 116
BISOPROLOL-HYDROCHLOROTHIAZIDE 136 136 44 164
COUMADIN 136 129 44 112
BYSTOLIC 131 131 49 96
ALCOHOL SWABS 127 114 50 115
SINGLE USE SWAB 122 122 51 108
ALLOPURINOL 120 91 52 41
DEXILANT 120 120 52 118
GLIPIZIDE XL 118 105 54 83
IMIPRAMINE HCL 116 111 R 55 592
CALCITRIOL 115 108 56 261
ACTOS 114 102 57 85
ENABLEX 114 102 57 284
TORSEMIDE 112 106 59 184
LISINOPRIL 111 104 60 5
TOPROL XL 111 111 60 227
ATENOLOL 110 98 62 12
RANITIDINE HCL 106 93 63 36
MELOXICAM 104 103 64 53
AMMONIUM LACTATE 103 94 65 91
KOMBIGLYZE XR 103 98 65 291
ESCITALOPRAM OXALATE 101 89 67 89
LANSOPRAZOLE 100 85 68 113
COLCRYS 100 75 68 170
ACTONEL 99 99 70 134
LANTUS SOLOSTAR 99 84 70 70
CLONIDINE HCL 96 96 72 79
IBUPROFEN 95 75 73 72
AMITIZA 93 80 74 197
ZETIA 92 80 75 68
ENALAPRIL MALEATE 92 76 75 22
AVODART 89 89 77 107
WARFARIN SODIUM 82 64 78 13
METOCLOPRAMIDE HCL 82 69 78 176
ADVAIR DISKUS 80 79 80 32
LYRICA 80 70 80 133
CILOSTAZOL 79 66 82 206
MATZIM LA 76 76 10 83 531
ONGLYZA 76 76 83 153
GLIPIZIDE-METFORMIN 70 61 85 366
ORPHENADRINE CITRATE 70 61 R 85 575
ENDOCET 70 70 S2 85 246
FLUTICASONE PROPIONATE 69 64 88 38
CHLORHEXIDINE GLUCONATE 67 67 89 202
AMLODIPINE BESYLATE-BENAZEPRIL 67 58 89 55
LANTUS 67 67 89 66
BENICAR 66 66 92 100
VENLAFAXINE HCL ER 65 55 93 186
PEN NEEDLE 63 61 94 144
SINGULAIR 63 60 94 62
BACLOFEN 61 49 96 173
GLIPIZIDE ER 61 61 96 117
LEXAPRO 60 58 98 193
FAMOTIDINE 59 59 99 58
PIOGLITAZONE-METFORMIN 58 55 R 100 457
PROPRANOLOL HCL 58 55 100 199
SUMATRIPTAN SUCCINATE 57 43 102 490
NASONEX 57 57 102 178
NITROGLYCERIN PATCH 56 56 104 149
ACETAMINOPHEN-CODEINE 56 37 S3 104 127
DICLOFENAC POTASSIUM 54 48 106 575
ZOVIRAX 54 50 106 313
NOVOLOG MIX 70-30 FLEXPEN 53 48 108 290
DICYCLOMINE HCL 52 49 109 224
DILTIAZEM 24HR CD 52 52 109 119
RANEXA 52 52 109 167
POTASSIUM CHLORIDE 52 43 109 34
COMBIVENT 51 51 113 156
CLOTRIMAZOLE-BETAMETHASONE 51 51 113 94
PROCTOZONE-HC 50 49 115 171
CLOTRIMAZOLE 50 45 115 296
GLYBURIDE-METFORMIN HCL 50 29 R 115 76
CITALOPRAM HBR 50 50 115 31
RAMIPRIL 50 50 115 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.